Patent details

EP2830621 Title: PHARMACEUTICAL DIAGNOSTIC

Basic Information

Publication number:
EP2830621
PCT Application Number:
EP2013056600
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137151692
PCT Publication Number:
WO2013144249
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL DIAGNOSTIC
French Title of Invention:
PRODUIT PHARMACEUTIQUE À DES FINS DIAGNOSTIQUES
German Title of Invention:
PHARMAZEUTISCHES DIAGNOSTIKUM
SPC Number:

Dates

Filing date:
27/03/2013
Grant date:
21/10/2020
EP Publication Date:
04/02/2015
PCT Publication Date:
03/10/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/10/2020
EP B1 Publication Date:
21/10/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/03/2021
Expiration date:
27/03/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/10/2020
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
MAIRA, Sauveur-Michel
Address:
Switzerland (CH)

2

Name:
FRITSCH, Christine
Address:
Switzerland (CH)

3

Name:
FURET, Pascal
Address:
Switzerland (CH)

Priority

1

Priority Number:
201261617284 P
Priority Date:
29/03/2012
Priority Country:
United States (US)

2

Priority Number:
201361767848 P
Priority Date:
22/02/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4439; A61P 35/00; C12N 15/11; G11B 20/00; C12Q 1/68;

Publication

European Patent Bulletin

Issue number:
202043
Publication date:
21/10/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages